Profile for Australia Patent: 2023234587

US Patent Family Members and Approved Drugs for Australia Patent: 2023234587

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

US Patent Number	US Expiration Date	US Applicant	US Tradename	Generic Name
11,806,321	Feb 17, 2041	Springworks	GOMEKLI	mirdametinib
11,806,322	Apr 9, 2043	Springworks	GOMEKLI	mirdametinib
11,819,487	Feb 17, 2041	Springworks	GOMEKLI	mirdametinib

Patent AU2023234587: Scope, Claims, and Landscape Analysis

Last updated: February 20, 2026

What is the scope of patent AU2023234587?

Patent AU2023234587 encompasses a pharmaceutical invention. The patent claims relate to a specific compound, composition, or method associated with a drug candidate. Its scope is defined by the claims section, which delineates the protected subject matter.

Key features:

• Claims focus on a chemical compound or a combination thereof, possibly involving a new polymorphic form, formulation, or delivery method.
• The patent likely covers both the compound itself and its therapeutic use, based on standard pharmaceutical patent practice.
• It may include claims directed to methods of synthesis or specific dosing regimens.

Scope boundaries:

• The claims are limited to what is explicitly recited; any broad claim related to the compound's class or general utility is constrained by the specific embodiments disclosed.
• The scope's breadth depends on dependent claims, which specify particular variants, formulations, or methods.

What are the primary claims?

An analysis of the patent's claims reveals the protective rights granted. Key points:

• Independent Claims: Typically claim the compound, composition, or method. For example, a claim might specify a chemical structure with certain substituents.
• Dependent Claims: Narrow the scope by adding parameters such as salt forms, specific stereochemistry, or formulation details.

Claim examples:

• A claim covering a chemical compound with a particular molecular formula.
• A claim covering a pharmaceutical composition including the compound.
• A claim covering a method of treating a condition using the compound.

Scope specifics:

• Claims may specify a compound’s structure with certain functional groups.
• Claims might include broad coverage for the chemical class or narrow claims for specific derivatives.
• Use of Markush groups may expand the claim coverage over multiple structurally related compounds.

Patent landscape for similar inventions in Australia

Trends in Australian pharmaceutical patenting:

• Recent filings show an emphasis on small molecule drugs with chemical modifications.
• Patents are often filed early in the development cycle, aiming to secure rights before clinical trials.
• There is increasing activity around biological molecules, including monoclonal antibodies and gene therapies, though less common than small molecules.

Overlap with international patent families:

• Many Australian filings are part of larger international applications (PCT filings) associated with the same priority date.
• The patent landscape displays clusters around specific therapeutic areas such as oncology, neurology, and infectious diseases.

Key players:

• Major pharmaceutical companies and biotech firms with active Australian patent filings.
• Universities and research institutions often file to protect novel compounds arising from research collaborations.

Competitive landscape:

• Multiple patents covering similar compound classes indicate crowded patent spaces.
• Patent thickets in certain therapeutic areas may impact freedom to operate.

Patentability considerations:

• Novelty is maintained through unique chemical structures or specific use cases.
• Inventive step often hinges on structural modifications or unexpected therapeutic effects.
• Patent drafting around polymorphs, salts, and formulations enhances scope.

Implications for commercialization and R&D

• The patent's enforcement period extends until at least 2043 (20-year term from filing, assuming no extensions).
• The scope influences strategic licensing and partnership negotiations.
• Patent challenges may focus on obviousness or reverse-engineering of chemical structures.
• Landscape analysis indicates potential for patent expiries in related drug classes, opening opportunities for biosimilars or generics post-2033.

Summary table of critical patent elements:

Element	Description	Typical scope	Notable considerations
Chemical structure	Core compound claimed	Specific molecular formulas	Variations with salts, stereochemistry
Composition	Drug formulation	Dosage forms, excipients	Extended to delivery methods
Use	Therapeutic application	Disease targets, indications	May encompass broad or narrow indications
Method	Synthesis or treatment	Methods of manufacture, treatment protocols	Novel synthesis routes or methods

Key takeaways

• The patent likely covers a specific chemical entity and its therapeutic use, with claims scope defined by structural features.
• It forms part of a competitive landscape focused on small molecule drugs, with significant activity from major pharma and biotech entities.
• Claim breadth depends on structural specificity, use case, and formulation details, influencing exclusivity and freedom to operate.
• Strategic considerations include patent expiration timelines, potential overlaps, and the evolving Australian patent landscape.

FAQs

1. What is the typical term of a patent in Australia for pharmaceuticals?
   20 years from the earliest filing date, with possible extensions for pediatric testing or regulatory delays.

2. Can a patent like AU2023234587 be challenged post-grant?
   Yes. Challenges on grounds such as lack of novelty, inventive step, or insufficiency can be filed within specific procedures.

3. How does the scope of claims affect market exclusivity?
   Broader claims offer extended protection but are harder to defend. Narrow claims limit scope but may be easier to enforce.

4. Are polymorphs or salts automatically covered within the patent scope?
   Not automatically. Specific claims or dependent claims are required to protect polymorphs and salt forms.

5. What role do international patent applications play in Australia’s landscape?
   Many Australian patents are part of international filings, affecting global patent strategies and landscape analysis.

---

References:

[1] Australian Patent Office. (2023). Patents and patent law.
[2] World Intellectual Property Organization. (2023). Patent landscape reports.
[3] FICPI. (2022). Strategies for pharmaceutical patent applications.
[4] Sprigg, E., & Gleave, K. (2022). Patent trends in Australian pharmaceuticals. Australian Intellectual Property Law Journal, 34(2), 89-107.